Valeant Pharmaceuticals Announces 2013 Annual Meeting Results

LAVAL, Quebec, May 21, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2013 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out below:

Name		For		Withheld
Ronald H. Farmer		235,731,934		1,964,748
Robert A. Ingram		233,865,876		3,830,806
Theo Melas-Kyriazi		237,081,508		615,174
G. Mason Morfit		235,623,283		2,073,399
J. Michael Pearson		232,521,825		5,174,857
Robert N. Power		235,168,850		2,527,832
Norma A. Provencio		237,125,741		570,941
Howard B. Schiller		221,521,559		16,175,123
Lloyd M. Segal		236,082,529		1,614,153
Katharine Stevenson		234,501,146		3,195,536

At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement; appointed PricewaterhouseCoopers LLP (United States) as the Company's independent registered public accounting firm until the close of the Company's 2014 annual meeting of shareholders; and approved the continuance of the Company from the Canada Business Corporations Act to the British Columbia Business Corporations Act.

The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site, www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
[email protected]

SOURCE: Valeant Pharmaceuticals International, Inc.

http://www.valeant.com

http://photos.prnewswire.com/prnh/20101025/LA87217LOGO